PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG puts annual forecast into concrete terms
Public disclosure of inside information according to article 17 MAR
Gilching (pta012/18.02.2022/09:40) - The Management Board expects revenues of between € 130 and € 140 for the Hoenle Group and an operating result (EBIT) of between € 14 and € 17 million in financial year 2021/2022.
Equipment & Systems Segment
Hönle's SteriWhite Air product line realised sales revenues of € 5.2 million with air disinfection systems in the first three months of the current financial year. Despite the existing subsidy programs for air purifiers in schools and daycare centres, the company thus sold fewer systems than originally planned and, consequently, the sales development of air disinfection equipment in this financial year is expected to be weaker than predicted. The further development of sales in this area will depend significantly on the course of the pandemic and the willingness of potential customers to invest in this technology. However, depending on the development, there is still the possibility that sales will develop better than currently anticipated.
Over the medium to long term, Management expects the business with UV-based disinfection systems to develop into an important pillar for the Hönle Group with a significant increase in sales and earnings contributions.
Moreover, the Management Board believes that the business with drying systems for the printing and coating market and with drying equipment for adhesives will develop favourably. The Management's positive outlook is underpinned by the high level of orders on hand in these application areas.
At present, orders on hand in the Equipment & Systems segment exceed the prior years' level by some 90%. Overall, due to the excellent order intake and the large number of customer projects, a very positive business development is expected for this segment.
The Adhesives segment's start into the new financial year was weaker than in the previous year. The still existing travel restrictions concerning China had a dampening effect. It is expected, however, that major adhesives projects will be realised by the end of the financial year.
Given the large number of high-potential adhesives projects, the Management Board assumes strong business development over the medium to long term. A further managing director, responsible for the international sale of adhesives, is to be entrusted with the further opening up of Chinese and US sales territories, in particular. In addition, the spatial capacities were expanded to include additional state-of-the-art laboratory space for the Research & Development, Application Technology and Quality Assurance areas.
Glass & Lamps Segment
The high demand for UV lamps in the area of air and water disinfection has contributed to the excellent business performance at uv-technik Speziallampen GmbH. Prospects in the air and water disinfection business are excellent and strong business development is therefore expected over the medium to long term in this area as well.
Long delivery times for furnace components resulted in delayed deliveries of significant furnaces and, in this context, in a restrained start of the Raesch Group into the new financial year.
Due to the high level of orders on hand, which currently exceeds the previous year's level by 60 %, in combination with a strong quartz glass market, the Management Board expects favourable business for the second half of the year.
In all, sales and earnings in the Glass & Lamps segment are expected to be clearly higher than in the previous year.
The 2021/2022 quarterly report will be published on 22 February 2022 as planned, and will then be available on the internet under https://www.hoenle.com/investor-relation/financial-information.
Dr. Hönle AG is a listed technology company headquartered in Gilching, Germany. With its nearly 700 employees, the Hönle Group develops innovative solutions for a wide variety of industrial manufacturing processes. One focus of its activities is the development and sale of industrial adhesives and casting compounds. Moreover, the company manufactures equipment for ink and paint drying, adhesives and plastic curing as well as for air, water and surface disinfection and sunlight simulation. In addition, the corporate group produces UV lamps for disinfection and drying processes, among others, and manufactures tubes and semi-finished products made of quartz glass for use in various branches of industry. The Hönle Group supplies technology and world market leaders worldwide and is represented by its own entities and partner companies in more than 20 countries.
emitter: Dr. Hönle AG
address: Nicolaus-Otto-Str. 2, 82205 Gilching
contact person: Peter Weinert
phone: +49 8105 2083 173
ISIN(s): DE0005157101 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate